Literature DB >> 10467270

Phenotypic variability of Filipino beta(o)-thalassemia/HbE patients in Indonesia.

I Setianingsih1, R Williamson, D Daud, A Harahap, S Marzuki, S Forrest.   

Abstract

Three Indonesian patients with identical genotypes, each compound heterozygotes for Filipino beta(o)-thalassemia/HbE, expressed different clinical severities. One patient has mild disease and is transfusion independent, while the other two are severely affected and transfusion dependent. The size of the Filipino beta(o)-globin gene deletion was confirmed to be 45 kb, resolving conflicting values given in the literature. Neither ameliorating genetic factors such as alpha-globin gene deletions or the XmnI restriction site polymorphism at position -158 upstream of the (G)gamma-globin gene, nor differences in beta-globin gene haplotype, explain the phenotypic variation. These observations have implications for the development of antenatal diagnosis in Indonesia, as at present it is not possible to give an accurate prediction of severity of phenotype for this common genotype. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10467270     DOI: 10.1002/(sici)1096-8652(199909)62:1<7::aid-ajh2>3.0.co;2-s

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  A commentary on molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.

Authors:  Iswari Setianingsih
Journal:  J Hum Genet       Date:  2014-02-06       Impact factor: 3.172

2.  Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.

Authors:  Lai Kuan Teh; Elizabeth George; Mei I Lai; Jin Ai Mary Anne Tan; Lily Wong; Patimah Ismail
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172

Review 3.  Haemoglobinopathies in southeast Asia.

Authors:  Suthat Fucharoen; Pranee Winichagoon
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.